You are here

  • Home
  • Archive
  • Volume 100, Issue 1
  • Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?

Article info

Article menu
Download PDFPDF
Archimedes
Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?

Authors

  1. Correspondence to Dr Jamie N Frediani, Department of Hematology/Oncology, Children's Hospital Los Angeles, 4650 Sunset Blvd, Mailstop #54, Los Angeles CA 90027, USA; Jnfrediani{at}gmail.com
View Full Text

Citation

Frediani JN, Phillips B
Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infection?
Archives of Disease in Childhood 2015;100:108-111.

Publication history

  • Received July 10, 2014
  • Revised October 10, 2014
  • Accepted October 21, 2014
  • First published November 12, 2014.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions